EGFR and non-small cell lung carcinoma: Circulating inflammatory markers such as C-reactive protein (CRP), cytokines, neutrophil-to-lymphocyte ratio (NLR), and lymphocyte-to-monocyte ratio (LMR) are associated with the prognosis of NSCLC patients receiving EGFR-TKIs (20, 23, 25–28).